CD5 and B-cell non-Hodgkin lymphoma: Considering that both TC and RK mice models develop mature B-cell lymphoma originating from the B1-cell lineage, specifically chronic lymphocytic leukemia (CLL) [9, 21], we assessed B1-cell expansion in peripheral blood using CD19 and CD5 surface markers.